Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S. Lunde, Christopher D. Huston|Nature Communications|2019Cited by 63
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitorsRajiv S. Jumani, Christopher D. Huston|Nature Communications|2019Cited by 50